ConductScience.org, home
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis
API referenceFor AI assistants

Trial · NCT01201356

Adverse events407

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 407

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherLymphopeniaBlood and lymphatic system disordersFingolimod 0.5 mg/Day2194,083
otherFatigueGeneral disordersFingolimod 0.5 mg/Day2324,083
otherBronchitisInfections and infestationsFingolimod 0.5 mg/Day2144,083
otherInfluenzaInfections and infestationsFingolimod 0.5 mg/Day2754,083
otherNasopharyngitisInfections and infestationsFingolimod 0.5 mg/Day7064,083
otherUpper respiratory tract infectionInfections and infestationsFingolimod 0.5 mg/Day3464,083
otherUrinary tract infectionInfections and infestationsFingolimod 0.5 mg/Day3354,083
otherHypercholesterolaemiaMetabolism and nutrition disordersFingolimod 0.5 mg/Day2124,083
otherArthralgiaMusculoskeletal and connective tissue disordersFingolimod 0.5 mg/Day2084,083
otherBack painMusculoskeletal and connective tissue disordersFingolimod 0.5 mg/Day2794,083
otherHeadacheNervous system disordersFingolimod 0.5 mg/Day3484,083
otherDepressionPsychiatric disordersFingolimod 0.5 mg/Day2054,083
otherHypertensionVascular disordersFingolimod 0.5 mg/Day2434,083
seriousAnaemiaBlood and lymphatic system disordersFingolimod 0.5 mg/Day34,083
seriousImmune thrombocytopenic purpuraBlood and lymphatic system disordersFingolimod 0.5 mg/Day14,083
seriousIron deficiency anaemiaBlood and lymphatic system disordersFingolimod 0.5 mg/Day14,083
seriousLeukopeniaBlood and lymphatic system disordersFingolimod 0.5 mg/Day14,083
seriousLymphadenopathyBlood and lymphatic system disordersFingolimod 0.5 mg/Day14,083
seriousLymphopeniaBlood and lymphatic system disordersFingolimod 0.5 mg/Day14,083
seriousThrombocytopeniaBlood and lymphatic system disordersFingolimod 0.5 mg/Day14,083

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01201356/events

API referenceFor AI assistants